Abrdn Healthcare Investor... (HQH)
NYSE: HQH
· Real-Time Price · USD
19.05
0.15 (0.79%)
At close: Oct 15, 2025, 3:59 PM
19.06
0.05%
After-hours: Oct 15, 2025, 05:36 PM EDT
Abrdn Healthcare Investors Balance Sheet Statement
Financials in USD. Fiscal
year is
October - September.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
Cash & Equivalents | 56.00 | 214.00 | 792.00 | 935.00 |
Short-Term Investments | n/a | n/a | n/a | n/a |
Cash & Short-Term Investments | 56.00 | 214.00 | 792.00 | 935.00 |
Receivables | 495.64K | 6.85M | 2.87M | 4.05M |
Accounts Receivables | 495.64K | 6.85M | 2.87M | 4.05M |
Other Receivables | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a |
Prepaid Expenses | 94.4K | 50.8K | 49.1K | 50.09K |
Other Current Assets | 13.79K | 32.74M | 39.79M | 8.3M |
Total Current Assets | 603.88K | 39.64M | 42.71M | 12.4M |
Property-Plant & Equipment | n/a | n/a | n/a | n/a |
Goodwill | n/a | n/a | n/a | n/a |
Intangible Assets | n/a | n/a | n/a | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a |
Long-Term Investments | 1.04B | 824.65M | 804.79M | 1.07B |
Tax Assets | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 21.56M | 68.2M | 78.78M | 88.44M |
Total Long-Term Assets | 1.06B | 892.85M | 883.57M | 1.16B |
Other Assets | n/a | n/a | n/a | n/a |
Total Assets | 1.06B | 932.49M | 926.28M | 1.17B |
Total Payables | n/a | n/a | n/a | n/a |
Account Payables | n/a | n/a | n/a | n/a |
Other Payables | n/a | n/a | n/a | n/a |
Accrued Expenses | 1.13M | 1.15M | 1.22M | 1.29M |
Short-Term Debt | n/a | n/a | 8.5M | 11.33M |
Current Capital Lease Obligations | n/a | n/a | n/a | n/a |
Tax Payables | n/a | n/a | n/a | n/a |
Deferred Revenue | n/a | n/a | n/a | n/a |
Other Current Liabilities | 263.64K | n/a | n/a | 3.01M |
Total Current Liabilities | 1.4M | 1.15M | 9.71M | 15.63M |
Long-Term Debt | n/a | n/a | n/a | n/a |
Non-Current Capital Lease Obligations | n/a | n/a | n/a | n/a |
Non-Current Deferred Revenue | n/a | n/a | n/a | n/a |
Non-Current Deferred Tax Liabilities | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | 1.15M | 9.71M | 15.63M |
Total Long-Term Liabilities | n/a | 1.15M | 9.71M | 15.63M |
Other Liabilities | n/a | n/a | n/a | n/a |
Capital Lease Obligations | n/a | n/a | n/a | n/a |
Total Liabilities | 1.4M | 1.15M | 9.71M | 15.63M |
Treasury Stock | n/a | n/a | n/a | n/a |
Preferred Stock | n/a | n/a | n/a | n/a |
Common Stock | 521.3K | 494.42K | 473.44K | 454.25K |
Retained Earnings | 117.95M | 5.97M | 24.82M | 303.1M |
Additional Paid-In Capital | 941.13M | 924.88M | 891.27M | 853.35M |
Comprehensive Income | n/a | n/a | n/a | n/a |
Other Stockholders Equity | n/a | n/a | n/a | n/a |
Shareholders Equity | 1.06B | 931.34M | 916.56M | 1.16B |
Total Equity | 1.06B | 931.34M | 916.56M | 1.16B |
Minority Interest | n/a | n/a | n/a | n/a |
Total Liabilities & Equity | 1.06B | 932.49M | 926.28M | 1.17B |
Total Investments | 1.04B | 824.65M | 804.79M | 1.07B |
Total Debt | n/a | n/a | 8.5M | 11.33M |
Net Debt | -56 | -214 | 8.49M | 11.33M |
Book Value | 1.06B | 931.34M | 916.56M | 1.16B |
Book Value Per Share | 20.33 | 18.84 | 19.36 | 25.47 |
Source: Financial Modeling Prep. Financial Sources.